This compound is a stable isotope labeled pharmaceutical impurity, specifically a deuterated form of nevirapine impurity B. It is primarily used as a reference standard in pharmaceutical research and quality control to ensure the purity and identity of drug substances.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1189717-29-0
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
active pharmaceutical ingredient
1,2-Dehydro-3-oxo Rocuronium Bromide
neuromuscular blocking agent intermediate
Sofosbuvir
active pharmaceutical ingredient
Beova
beta3-adrenergic receptor agonist
Nevirapina
active pharmaceutical ingredient
7-methyl-2-(2,2,3,3-tetradeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
active pharmaceutical ingredient
2-cyclopropyl-7-(trideuteriomethyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
deuterated nevirapine intermediate
8-Hydroxynevirapine
reference standard for impurity testing
7-methyl-2-(1,2,2,3,3-pentadeuteriocyclopropyl)-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
NQDJXKOVJZTUJA-QTQWIGFBSA-N
[2H]C1(C(C1([2H])N2C3=C(C=CC=N3)C(=O)NC4=C(C=CN=C42)C)([2H])[2H])[2H]